MISTY GILLILAND: Open Payments
NPI 1003215500 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,234 in 123 payments from 23 companies in 2025. Trend: 2023 $1,828 · 2024 $1,981 · 2025 $2,234
Food & beverage: $2,234
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 20 | $296 |
| Lilly USA, LLC | 22 | $279 |
| Insulet Corporation | 22 | $248 |
| Novo Nordisk Inc | 11 | $226 |
| Abbott Laboratories | 8 | $157 |
| CeQur Corporation | 1 | $149 |
| Dexcom, Inc. | 5 | $123 |
| Ascendis Pharma Endocrinology Inc | 6 | $119 |
| Sequel Med Tech, LLC | 5 | $100 |
| Medtronic, Inc. | 2 | $90 |
Products named: JARDIANCE, Omnipod, FREESTYLE LIBRE 3, CeQur Simplicity, Rybelsus, Dexcom G6 Transmitter, Yorvipath, Ozempic.
Industry payments across TN — which companies pay providers there.
